Envoy Medical, Inc. (NASDAQ:COCHW – Get Free Report) saw a large growth in short interest in the month of October. As of October 15th, there was short interest totaling 8,851 shares, a growth of 308.3% from the September 30th total of 2,168 shares. Based on an average daily volume of 16,216 shares, the short-interest ratio is presently 0.5 days.
Envoy Medical Stock Down 0.4%
Shares of COCHW traded down $0.00 during mid-day trading on Wednesday, reaching $0.03. The company had a trading volume of 540 shares, compared to its average volume of 26,385. Envoy Medical has a 52-week low of $0.02 and a 52-week high of $0.10. The stock has a 50 day moving average of $0.04 and a two-hundred day moving average of $0.05.
About Envoy Medical
Envoy Medical is a medical technology company focused on developing fully implanted hearing devices for people with hearing loss. The company’s technologies are designed to use the body’s natural anatomy to capture sound and deliver auditory stimulation, with the goal of providing hearing restoration without the external components required by many conventional hearing devices.
Envoy Medical’s lead product is the Acclaim cochlear implant, a fully implanted device intended for adults with sensorineural hearing loss who may benefit from cochlear implantation.
Recommended Stories
- Five stocks we like better than Envoy Medical
- Boeing Got Its MAX 10 Approval, But Q3 Delivered a Reality Check
- The Invisible AI Backbone: Corning’s AI Fiber Play
- Heavy Metal: Why Nucor Could Be an Overlooked AI Infrastructure Winner
- Why Tesla’s Upside Is About More Than a SpaceX Merger
Receive News & Ratings for Envoy Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envoy Medical and related companies with MarketBeat.com's FREE daily email newsletter.
